Answer
Yes, prolonged treatment with pharmacologic doses of Depo-Medrone (methylprednisolone acetate) may suppress the hypothalamic-pituitary-adrenal axis, causing secondary adrenal insufficiency that can persist for months after stopping treatment, and abrupt withdrawal can cause fatal acute adrenal insufficiency.
Sources for this answer
- Depo-Medrone 40mg/ml Suspension for InjectionPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 30Document updated
Sources checked